Gilead Sciences, Inc. (ETR:GIS)
94.18
+2.66 (2.91%)
Jun 27, 2025, 5:35 PM CET
Gilead Sciences Employees
Gilead Sciences had 17,600 employees as of December 31, 2024. The number of employees decreased by 400 or -2.22% compared to the previous year.
Employees
17,600
Change (1Y)
-400
Growth (1Y)
-2.22%
Revenue / Employee
€1,510,547
Profits / Employee
€313,569
Market Cap
117.50B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 24,363 |
Gilead Sciences News
- 19 hours ago - Exas, Guardant, Gilead among gainers as Supreme Court ensures free preventive care - Seeking Alpha
- 20 hours ago - Gilead shares rise after US top court ruling on preventative coverage - Reuters
- 21 hours ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD - PRNewsWire
- 2 days ago - Kymera Shrugs Off Sanofi Bust With Gilead Deal--But There Are Caveats - Seeking Alpha
- 2 days ago - Gilead and Kymera in pact to develop cancer drugs - Seeking Alpha
- 2 days ago - Gilead Bets On Kymera's CDK2 Molecular Glue Degrader For New Cancer Therapies - Benzinga
- 2 days ago - Gilead signs up to $750 million cancer drug deal with Kymera Therapeutics - Reuters
- 3 days ago - Gilead Sciences and Kymera Therapeutics Enter Into Exclusive Option and License Agreement to Develop Novel Oral Molecular Glue CDK2 Degraders - Business Wire